Abstract:BACKGROUND:Blood hemoperfusion with resin adsorption can clean larger molecules that exceed the molecular weight cutoff of combined continuous veno-venous hemofiltration (CVVH). Hence blood hemoperfusion with resin adsorption combined CVVH (HP+CVVH) has higher ability of mediator clearance, and can improve clinical outcomes in theory. This study aimed to investigate the effect of blood hemoperfusion with resin adsorption combined continuous veno-venous hemofiltration (HP+CVVH) on plasm cytokines like TNF-α, IL-1β, IL-6, cellular immunity and prognosis in patients with multiple organ dysfunction syndrome (MODS).METHODS:This was a prospective, randomized clinical trial. A total of 30 patients who had been diagnosed with MODS were enrolled in this study. Patients were randomly allocated to routine treatment+HP+CVVH group (treatment group) and routine treatment+only CVVH group (control group). In the treatment group, patients received blood hemoperfusion with resin adsorption for 2 hours, and then received CVVH for 10 hours every day. In the control group, patients received CVVH for 12 hours only every day. The patients in the two groups received blood purification therapy for three days. The plasma of patients in the treatment group was obtained at 0, 2, 12, 24, 26, 36, 48, 50, 60 hours, 5th day, 7th day and 10th day, respectively. The plasma of patients in the control group was obtained at 0, 12, 24, 36, 48, 60 hours, 5th day, 7th day and 10th day, respectively. APACHE II score, T-lymphocytes subpopulations, blood lactate acid concentration, heart rate, breathing rate, and oxygenation index were observed.RESULTS:Plasma cytokines like TNF-α, IL-1β, IL-6 decreased markedly after HP (P<0.01); T-lymphocytes subpopulations CD3+, CD4+, CD8+, CD4+/CD8+ increased after HP+CVVH or only CVVH. The plasma concentrations of TNF-α, IL-1β and IL-6 in the two groups were not markedly different at 12, 36, and 50 hours. But on the 5th day, the plasma concentrations of TNF-α, IL-1β and IL-6 in the treatment group were lower than those in the control group (P<0.05). On the 28th day, 5 patients died in the treatment group, and 6 patients in the control group.CONCLUSIONS:Both HP+CVVH and CVVH can clean plasma cytokines like TNF-α, IL-1β, and IL-6, and improve cellular immunity and clinical symptoms and signs of patients. Compared with only CVVH, the plasma concentrations of TNF-α, IL-1β and IL-6 were lower on the 5th day, and patients have an increased survival rate on the 28 day in the HP+CVVH group.

Changes of Cytokines in Patients with Multiple Organ Dysfunction Syndrome after Actue Cerebrovascular Diseases

Peripheral Inflammatory Markers in Patients with Prolonged Disorder of Consciousness after Severe Traumatic Brain Injury.

[Changes in Pro-Inflammatory Cytokines and Media and Peptide Hormones During Multiple Organ Dysfunction Syndrome Following Acute Abdominal Diseases].

Clinical Study of Plasma Cytokines in the Elderly Critical Patients with Multiple Organ Dysfunction Syndrome

Change in serum levels of soluble Fas and soluble FasL in patients with multiple organ dysfunction syndrome]

Explore the mechanism of systemic inflammatory response syndrome induced MODS in acute infarction

Clinical Study on Blood Hemoperfusion Resin Adsorption Series Connected Continuous Venous-Venous Hemofiltration Treating the Patients with Multiple Organ Dysfunction Syndromes

Relationship of vascular endothelial dysfunction to the patients with systemic inflammatory response syndrome and multiple organ dysfunction syndrome

Expression and relationship of PPARγand NF -κB in peripheral blood mononuclear cells of multiple organ dysfunction syndrome patients

Changes of Cytokines in the Multiple Organ Dysfunction Syndrome in Animals

Characteristics of CD4+CD25+Foxp3+ Regulatory T Cells in Patients with Multiple Organ Dysfunction Syndrome.

Relationships between islet β-cell function and infection,inflammation and major organ function in multiple organ dysfunction syndrome patients with severe traumatic hemorrhage

Changes of Interleukin 2 and Soluble Interleukin 2 Receptor Serum Level and Multiple Organ Dysfunction Syndrome in Severely Traumatic Patients

Change of Splenic HMGB1 Expression Influences Dendritic Cell Activity of Spleen in Mice with MODS

Changes of Pro-and Anti-Inflammatory Cytokines in Serum and Cerebrospinal Fluid of Patients with Different Kinds of Dementias

Blood Hemoperfusion with Resin Adsorption Combined Continuous Veno-Venous Hemofiltration for Patients with Multiple Organ Dysfunction Syndrome.

THE CHANGES AND CLINICAL SIGNIFICANCE OF SERUM MYOCARDIAL ENZYMES IN PATIENTS WITH MULTIPLE ORGAN DYSFUNCTION SYNDROME

[Effects of High-Volume Hemofiltration on Serum Levels of Tumor Necrosis Factor and Its Receptors in Patients with Multiple Organ Dysfunction Syndromes].

[Study on High Mobility Group-1 Protein in Patients with Multiple Trauma].

Abstract TMP119: Alterations Of Inflammatory Cytokines In Super-acute Stroke Patients And The Potential Pathogenesis

Biomarkers of Bacterial Translocation and Intestinal Wall Damage in Patients With Multiple Organ Dysfunction Syndrome